Literature DB >> 3802058

Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

H Tokuda, H Ohigashi, K Koshimizu, Y Ito.   

Abstract

Ursolic acid (UA) and oleanolic acid (OA), which had been isolated from Glechoma hederacea as inhibitors of Epstein-Barr virus (EBV) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), were tested against inhibitory effect on tumor promotion by TPA in vivo. They inhibited effectively the tumor promotion in mouse skin and the activities were comparable to that of a known inhibitor of tumor promotion, retinoic acid (RA). Interestingly, UA was more effective on a single application before initial TPA-treatment than on a continuous application before each TPA-treatment, while OA and RA were ineffective in the same treatment. These data suggest that the role of UA for inhibitory action on tumor promotion differs slightly from those of RA and OA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3802058     DOI: 10.1016/0304-3835(86)90067-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  29 in total

1.  A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.

Authors:  Kim Wilkinson; Justin D Boyd; Marcie Glicksman; Kathryn J Moore; Joseph El Khoury
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

2.  DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice.

Authors:  Yuqing Yang; Ran Yin; Renyi Wu; Christina N Ramirez; Davit Sargsyan; Shanyi Li; Lujing Wang; David Cheng; Chao Wang; Rasika Hudlikar; Hsiao-Chen Kuo; Yaoping Lu; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2019-06-25       Impact factor: 4.784

Review 3.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

4.  Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.

Authors:  Rui-Xin Lin; Lu-Lu Gong; Li-Mei Fan; Zhong-Kai Zhao; Shu-Li Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents.

Authors:  Jin Tatsuzaki; Kyoko Nakagawa-Goto; Harukuni Tokuda; Kuo-Hsiung Lee
Journal:  J Asian Nat Prod Res       Date:  2010-03       Impact factor: 1.569

6.  Effect of Combined Treatment with Ursolic Acid and Resveratrol on Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate.

Authors:  Jiyoon Cho; Okkyung Rho; Jacob Junco; Steve Carbajal; Dionicio Siegel; Thomas J Slaga; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-22

Review 7.  Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.

Authors:  Ana B Ramos-Hryb; Francis L Pazini; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

8.  Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.

Authors:  Andrew T Nelson; Andrew M Camelio; Karin R Claussen; Jiyoon Cho; Lisa Tremmel; John DiGiovanni; Dionicio Siegel
Journal:  Bioorg Med Chem Lett       Date:  2015-07-22       Impact factor: 2.823

9.  Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids.

Authors:  H Y Lee; H Y Chung; K H Kim; J J Lee; K W Kim
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.

Authors:  Hyuck Kim; Christina N Ramirez; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  J Nutr Biochem       Date:  2015-09-28       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.